Takeda Pharmaceutical Company Limited
HETEROCYCLIC AMIDE COMPOUND
Last updated:
Abstract:
Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
14 Sep 2017
Issue date:
28 Nov 2019